Literature DB >> 9042250

P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.

I S Van Leeuwen1, E Hellmèn, C J Cornelisse, B Van den Burgh, G R Rutteman.   

Abstract

Alterations in the p53 gene are frequently observed in a wide variety of human cancers. To elucidate the role of p53 in tumorigenesis of the dog, we analyzed nine mammary tumor cell lines, and the primary or metastatic tumors used for their establishment, for the presence of genomic p53 abnormalities. Possible genomic rearrangements were analyzed by Southern blotting using a canine cDNA probe. More subtle alterations were identified by single strand conformation polymorphism (SSCP) analysis for which we partially characterized the canine p53 gene (codon 109-388 as compared to the human gene). The presence of mutations in SSCP fragments with altered mobility was confirmed by DNA sequencing. Three of the nine cell lines showed a mutated p53 gene. All were missense mutations accompanied by loss of the wild type allele. The point mutations, at codon 176 (TGC * TTC), 236 (TAC * AAC) and 245 (GGC * GCC), were all located in one of the four regions that are frequently affected in human cancers. Analysis of the DNA extracted from the tumors of origin demonstrated the presence of two of these point mutations. These findings indicate the involvement of the p53 gene in the genesis of canine tumors in a way comparable to that of human tumors.

Entities:  

Mesh:

Year:  1996        PMID: 9042250

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms.

Authors:  B Mayr; M Reifinger; K Alton
Journal:  Vet Res Commun       Date:  1999-08       Impact factor: 2.459

Review 3.  Comparative oncology today.

Authors:  Melissa C Paoloni; Chand Khanna
Journal:  Vet Clin North Am Small Anim Pract       Date:  2007-11       Impact factor: 2.093

Review 4.  Heat shock proteins in animal neoplasms and human tumours--a comparison.

Authors:  Mariarita Romanucci; Tania Bastow; Leonardo Della Salda
Journal:  Cell Stress Chaperones       Date:  2008-03-12       Impact factor: 3.667

5.  Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin.

Authors:  Bart Spee; Martijn D B Jonkers; Brigitte Arends; Gerard R Rutteman; Jan Rothuizen; Louis C Penning
Journal:  Mol Cancer       Date:  2006-09-05       Impact factor: 27.401

6.  Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.

Authors:  N Veldhoen; J Watterson; M Brash; J Milner
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression.

Authors:  Elpetra P M Timmermans-Sprang; Ana Gracanin; Jan A Mol
Journal:  BMC Cancer       Date:  2015-07-25       Impact factor: 4.430

8.  Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.

Authors:  Ana Gracanin; Elpetra P M Timmermans-Sprang; Monique E van Wolferen; Nagesha A S Rao; Juraj Grizelj; Silvijo Vince; Eva Hellmen; Jan A Mol
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

9.  Multiplex Gene Expression Profiling of 16 Target Genes in Neoplastic and Non-Neoplastic Canine Mammary Tissues Using Branched-DNA Assay.

Authors:  Florenza Lüder Ripoli; Susanne Conradine Hammer; Annika Mohr; Saskia Willenbrock; Marion Hewicker-Trautwein; Bertram Brenig; Hugo Murua Escobar; Ingo Nolte
Journal:  Int J Mol Sci       Date:  2016-09-21       Impact factor: 5.923

Review 10.  In vitro comparative models for canine and human breast cancers.

Authors:  Simona Visan; Ovidiu Balacescu; Ioana Berindan-Neagoe; Cornel Catoi
Journal:  Clujul Med       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.